Food News and Research

RSS

Supplemental Manufacturing and Ingredients forges manufacturing agreement with HealthSport's subsidiary, InnoZen

InnoZen, Inc., a wholly owned subsidiary of HealthSport, Inc. (OTC Bulletin Board: HSPO) announced today that it has entered into a manufacturing agreement with Supplemental Manufacturing and Ingredients, LLC ("SMI"), a cGMP certified manufacturer based in Tempe, Arizona. As part of the Agreement, SMI has committed to purchasing $1,000,000 worth of HealthSport common stock.

20 Aug 2009

New Orleans city selects Upp Technology solution for improving mobile inventory management effciency

The City of New Orleans Department of Homeland Security and the City of New Orleans Fire Department have selected Upp Technology, Inc. to help improve the efficiency of their day-to-day operations. New Orleans chose Upp’s irms|EM (Emergency Management) solution, deployed on the irms|Go-Kit for a mobile inventory management system allowing the city to track inventory through the use of bar-coding at their warehouses and storerooms. Furthermore, the same Go-Kits can then be redeployed to the field in times of emergency to receive and distribute cots, water, food, and other critical supplies needed in Emergency Response.

20 Aug 2009

Anthem Media Group acquires Ascend Media's Allied Healthcare division

Anthem Media Group (AMG) announced today its acquisition of Ascend Media's Los Angeles-based medical media division for an undisclosed sum. The news comes just days after Inc. Magazine named the Kansas City-based Anthem one of the nation's fastest-growing companies.

20 Aug 2009

Dey's Albuterol Sulfate Inhalation Solution lots stolen in Texas

Dey L.P., a subsidiary of Mylan Inc., today issued an advisory regarding two lots of its Albuterol Sulfate Inhalation Solution, 0.083%, unit-dose vials. The lots were on a tractor-trailer that was stolen in McKinney, Texas.

20 Aug 2009

Cardiovascular Systems' revenues in fourth-quarter of 2009 increases to $15.7 million

Cardiovascular Systems, Inc. (CSI), a medical device company developing and commercializing innovative interventional treatment systems for vascular disease, today reported financial results for its fourth quarter and fiscal year ended June 30, 2009.

19 Aug 2009

FDA approves Hiberix Haemophilus influenzae type b vaccine

In response to a U.S. shortage of a vaccine to protect infants from Haemophilus influenzae type b (Hib), GlaxoSmithKline (NYSE: GSK) has received accelerated approval from the FDA (Food and Drug Administration) for Hiberix((R)) [Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate)] as a booster dose in children 15 months through four years of age. Hib is an often severe and potentially deadly bacterial infection that can cause meningitis.

19 Aug 2009

Mylan files lawsuit against Pittsburgh Post-Gazette, Post-Gazette reporters

Mylan Inc. (Nasdaq: MYL) today announced that the company and its subsidiary Mylan Pharmaceuticals Inc. filed a civil lawsuit in the Circuit Court of Monongalia County, W.Va., against the Pittsburgh Post-Gazette, Post-Gazette reporters Len Boselovic and Patricia Sabatini, and others as yet unknown.

19 Aug 2009

U.S. Food and Drug Administration launches new Center for Tobacco Products

The U.S. Food and Drug Administration today launched its new Center for Tobacco Products in an historic effort to curb the hundreds of thousands of deaths caused by those products each year.

19 Aug 2009

New non-toxic and environmentally friendly method for making tiny nanorods of zinc oxide

A non-toxic and environmentally friendly way to make tiny nanorods of zinc oxide has been developed for the first time by researchers in Saudi Arabia. The approach, described in the current issue of the International Journal of Nanoparticles, could allow the nanorods to be used safely in medical and for other applications.

19 Aug 2009

Newly discovered anti-aging gene linked to high blood pressure

Researchers at the University of Oklahoma Health Sciences Center have shown the first link between a newly discovered anti-aging gene and high blood pressure. The results, which appear this month in the journal Hypertension, offer new clues on how we age and how we might live longer.

19 Aug 2009

U.S. FDA approval of miconazole MBT represents a significant milestone for Strativa Pharmaceuticals

Strativa Pharmaceuticals, the proprietary products division of a wholly owned subsidiary of Par Pharmaceutical Companies, Inc. (NYSE: PRX), today announced that the U.S. Food and Drug Administration (FDA) has accepted the new drug application (NDA) for miconazole Lauriad((R)) mucoadhesive buccal tablets (MBT) to treat oropharyngeal candidiasis (OPC).

19 Aug 2009

Researchers find connection between eye disease and arginase

Elevated levels of the enzyme arginase contribute to vascular eye damage and Medical College of Georgia researchers say therapies to normalize its levels could halt progression of potentially blinding diseases such as diabetic retinopathy.

19 Aug 2009

Sinovac Biotech announces positive results from clinical trial of H1N1 vaccine

Sinovac Biotech Ltd. announced today positive top-line results from the completed clinical trial for its internally-developed H1N1 vaccine. The clinical data unblinding conference was held in Beijing on the afternoon of August 17, 2009. Notably, Sinovac is the first company worldwide to complete clinical trials for the H1N1 vaccine.

19 Aug 2009

Orient Pharma granted commercialization rights for a drug candidate by DURECT

DURECT Corporation today announced that it has signed a development and license agreement with Orient Pharma Co., Ltd., a diversified multinational pharmaceutical, healthcare and consumer products company with headquarters in Taiwan, under which DURECT has granted to Orient Pharma development and commercialization rights in selected Asian and South Pacific countries to a drug candidate based on DURECT's ORADUR(R) Technology and one specified active pharmaceutical ingredient for the treatment of attention deficit hyperactivity disorder (ADHD).

19 Aug 2009

BioAlliance Pharma's new drug application for oropharyngeal candidiasis treatment accepted by the FDA

BioAlliance Pharma SA (Paris:BIO), a company dedicated to the treatment and supportive care of cancer and AIDS patients, today announced that the U.S. Food and Drug Administration (FDA) has accepted the new drug application (NDA) for miconazole Lauriad® (Loramyc®) Mucoadhesive Buccal Tablets (MBT) to treat oropharyngeal candidiasis (OPC). Miconazole Lauriad® delivers the antifungal miconazole via a mucoadhesive buccal tablet that is designed to enable once-daily dosing of the active ingredient at the site of infection.

19 Aug 2009

CSL Biotherapies to supply Afluria influenza vaccines from newly licensed packaging facility

CSL Biotherapies, a subsidiary of CSL Limited, one of the world's leading manufacturers of influenza vaccine, announced today that the U.S. Food and Drug Administration (FDA) has licensed the company’s newest vaccine filling and packaging facility, located in Kankakee, Ill. The facility, part of an investment to expand CSL’s U.S. influenza vaccine production capabilities, includes a high-speed, single-dose vaccine syringe filling line.

19 Aug 2009

Researchers reveal new ways to detect the hidden biases of medical research

A study by researchers at the University of Leicester has revealed new ways to spot whether medical research has hidden biases. Writing in the prestigious British Medical Journal, Santiago Moreno and his colleagues demonstrate how to spot 'publication bias' in the reporting of clinical trials which potentially form the basis of Government and NHS health policies.

19 Aug 2009

Asia needs irrigation, farming reform to avoid 'chronic food shortages'

To avert "chronic food shortages and social unrest," Asia must improve its irrigation and farming processes, according to a study, issued by the U.N.'s Food and Agriculture Organization (FAO) and the International Water Management Institute (IWMI), Agence France-Presse reports. The study found that by 2050, Asia is expected to have an additional 1.5 billion people, which would put "more pressure on already scarce food supplies," the news service writes.

19 Aug 2009

SFDA approves China Pharma Holdings' generic Omeprazole Sodium injection

China Pharma Holdings, Inc., which develops, manufactures, and markets specialty pharmaceutical products in China, today announced that it has received approval from the Chinese State Food and Drug Administration ("SFDA) for the production of generic Omeprazole Sodium injections.

19 Aug 2009

Electronic Cigarette Association calls for a law restricting the sale of E-Cigarettes to underage smokers

In a letter sent to Congressional members on August 14, the Electronic Cigarette Association (ECA) criticized the recent Food and Drug Administration (FDA) study on electronic cigarettes as it failed to follow standard scientific protocols and was too narrow in scope. In addition, the letter called on Congress to enact legislation that would make it illegal to sell electronic cigarettes to those below the legal age of smoking.

19 Aug 2009

Food News and Research

Supplemental Manufacturing and Ingredients forges manufacturing agreement with HealthSport's subsidiary, InnoZen

New Orleans city selects Upp Technology solution for improving mobile inventory management effciency

Anthem Media Group acquires Ascend Media's Allied Healthcare division

Dey's Albuterol Sulfate Inhalation Solution lots stolen in Texas

Cardiovascular Systems' revenues in fourth-quarter of 2009 increases to $15.7 million

FDA approves Hiberix Haemophilus influenzae type b vaccine

Mylan files lawsuit against Pittsburgh Post-Gazette, Post-Gazette reporters

U.S. Food and Drug Administration launches new Center for Tobacco Products

New non-toxic and environmentally friendly method for making tiny nanorods of zinc oxide

Newly discovered anti-aging gene linked to high blood pressure

U.S. FDA approval of miconazole MBT represents a significant milestone for Strativa Pharmaceuticals

Researchers find connection between eye disease and arginase

Sinovac Biotech announces positive results from clinical trial of H1N1 vaccine

Orient Pharma granted commercialization rights for a drug candidate by DURECT

BioAlliance Pharma's new drug application for oropharyngeal candidiasis treatment accepted by the FDA

CSL Biotherapies to supply Afluria influenza vaccines from newly licensed packaging facility

Researchers reveal new ways to detect the hidden biases of medical research

Asia needs irrigation, farming reform to avoid 'chronic food shortages'

SFDA approves China Pharma Holdings' generic Omeprazole Sodium injection

Electronic Cigarette Association calls for a law restricting the sale of E-Cigarettes to underage smokers

Understanding cultivated meat and its global potential eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News